|
1
|
Ma Y, Wu Q, Li X, Gu X, Xu J and Yang J:
Pancreatic cancer: From bench to bedside. Ann Transl Med.
4:4582016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu Q, Fu R, Yin G, Liu X, Liu Y and Xiang
M: Microarray-based gene expression profiling reveals genes and
pathways involved in the oncogenic function of REG3A on pancreatic
cancer cells. Gene. 578:263–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Q, Wang H, Zogopoulos G, Shao Q, Dong
K, Lv F, Nwilati K, Gui XY, Cuggia A, Liu JL and Gao ZH: Reg
proteins promote acinar-to-ductal metaplasia and act as novel
diagnostic and prognostic markers in pancreatic ductal
adenocarcinoma. Oncotarget. 7:77838–77853. 2016.PubMed/NCBI
|
|
5
|
Liu X, Wang J, Wang H, Yin G, Liu Y, Lei X
and Xiang M: REG3A accelerates pancreatic cancer cell growth under
IL-6-associated inflammatory condition: Involvement of a
REG3A-JAK2/STAT3 positive feedback loop. Cancer Lett. 362:45–60.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Zhou H, Han Y, Liu X, Wang M, Wang
X, Yin G, Li X and Xiang M: SOCS3 methylation in synergy with Reg3A
overexpression promotes cell growth in pancreatic cancer. J Mol Med
(Berl). 92:1257–1269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen
RP, Chen MJ and Jin RF: REG3A promotes the proliferation,
migration, and invasion of gastric cancer cells. Onco Targets Ther.
10:2017–2023. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye Y, Xiao L, Wang SJ, Yue W, Yin QS, Sun
MY, Xia W, Shao ZY and Zhang H: Up-regulation of REG3A in
colorectal cancer cells confers proliferation and correlates with
colorectal cancer risk. Oncotarget. 7:3921–3933. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fukushima N, Koopmann J, Sato N, Prasad N,
Carvalho R, Leach SD, Hruban RH and Goggins M: Gene expression
alterations in the non-neoplastic parenchyma adjacent to
infiltrating pancreatic ductal adenocarcinoma. Mod Pathol.
18:779–787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie MJ, Motoo Y, Iovanna JL, Su SB,
Ohtsubo K, Matsubara F and Sawabu N: Overexpression of
pancreatitis-associated protein (PAP) in human pancreatic ductal
adenocarcinoma. Digest Dis Sci. 48:459–464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yue Q, Gao G, Zou G, Yu H and Zheng X:
Natural products as adjunctive treatment for pancreatic cancer:
Recent trends and advancements. Biomed Res Int. 2017:84125082017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marasini B and Sahu RP: Natural
anti-cancer agents: Implications in gemcitabine-resistant
pancreatic cancer treatment. Mini Rev Med Chem. 17:920–927. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Fu X, Duan D, Liu X, Xu J and Gao X:
Extraction and identification of phlorotannins from the brown alga,
sargassum fusiforme (Harvey) setchell. Mar Drugs. 15(pii): E492017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang MC, Cha SH, Wijesinghe WA, Kang SM,
Lee SH, Kim EA, Song CB and Jeon YJ: Protective effect of marine
algae phlorotannins against AAPH- induced oxidative stress in
zebrafish embryo. Food Chem. 138:950–955. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee MS, Shin T, Utsuki T, Choi JS, Byun DS
and Kim HR: Isolation and identification of phlorotannins from
Ecklonia stolonifera with antioxidant and hepatoprotective
properties in tacrine-treated HepG2 cells. J Agric Food Chem.
60:5340–5349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim AD, Kang KA, Piao MJ, Kim KC, Zheng J,
Yao CW, Cha JW, Hyun CL, Kang HK, Lee NH and Hyun JW:
Cytoprotective effect of eckol against oxidative stress-induced
mitochondrial dysfunction: Involvement of the FoxO3a/AMPK pathway.
J Cell Biochem. 115:1403–1411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jung HA, Kim JI, Choung SY and Choi JS:
Protective effect of the edible brown alga Ecklonia stolonifera on
doxorubicin-induced hepatotoxicity in primary rat hepatocytes. J
Pharm Pharmacol. 66:1180–1188. 2014.PubMed/NCBI
|
|
18
|
Ahn BR, Moon HE, Kim HR, Jung HA and Choi
JS: Neuroprotective effect of edible brown alga Eisenia bicyclis on
amyloid beta peptide-induced toxicity in PC12 cells. Arch Pharm
Res. 35:1989–1998. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang SM, Cha SH, Ko JY, Kang MC, Kim D,
Heo SJ, Kim JS, Heu MS, Kim YT, Jung WK and Jeon YJ:
Neuroprotective effects of phlorotannins isolated from a brown
alga, Ecklonia cava, against H2O2-induced oxidative stress in
murine hippocampal HT22 cells. Environ Toxicol Pharmacol.
34:96–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jung HA, Roy A, Jung JH and Choi JS:
Evaluation of the inhibitory effects of eckol and dieckol isolated
from edible brown alga Eisenia bicyclis on human monoamine oxidases
A and B. Arch Pharm Res. 40:480–491. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jung HA, Jung HJ, Jeong HY, Kwon HJ, Ali
MY and Choi JS: Phlorotannins isolated from the edible brown alga
Ecklonia stolonifera exert anti-adipogenic activity on 3T3-L1
adipocytes by downregulating C/EBPα and PPARγ. Fitoterapia.
92:260–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jung HA, Jin SE, Ahn BR, Lee CM and Choi
JS: Anti- inflammatory activity of edible brown alga Eisenia
bicyclis and its constituents fucosterol and phlorotannins in
LPS-stimulated RAW264. 7 macrophages. Food Chem Toxicol.
59:199–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kang YM, Eom SH and Kim YM: Protective
effect of phlorotannins from Eisenia bicyclis against
lipopolysaccharide-stimulated inflammation in HepG2 cells. Environ
Toxicol Pharmacol. 35:395–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noda H, Amano H, Arashima K, Hashimoto S
and Nisizawa K: Studies on the antitumor activity of marine algae.
Nippon Suisan Gakk. 55:1259–1264. 1989. View Article : Google Scholar
|
|
25
|
Hyun KH, Yoon CH, Kim RK, Lim EJ, An S,
Park MJ, Hyun JW, Suh Y, Kim MJ and Lee SJ: Eckol suppresses
maintenance of stemness and malignancies in glioma stem-like cells.
Toxicol Appl Pharmacol. 254:32–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ochoa JJ, Farquharson AJ, Grant I, Moffat
LE, Heys SD and Wahle KW: Conjugated linoleic acids (CLAs) decrease
prostate cancer cell proliferation: Different molecularmechanisms
for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis.
25:1185–1191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pesic M and Greten FR: Inflammation and
cancer: Tissue regeneration gone awry. Curr Opin Cell Biol.
43:55–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hamada S, Masamune A and Shimosegawa T:
Inflammation and pancreatic cancer: Disease promoter and new
therapeutic target. J Gastroenterol. 49:605–617. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gukovsky I, Li N, Todoric J, Gukovskaya A
and Karin M: Inflammation, autophagy, and obesity: Common features
in the pathogenesis of pancreatitis and pancreatic cancer.
Gastroenterology. 144:1199–1209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zambirinis CP, Pushalkar S, Saxena D and
Miller G: Pancreatic cancer, inflammation, and microbiome. Cancer
J. 20:195–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao X, Fan W, Xu Z, Chen H, He Y, Yang G,
Hu H, Tang S, Wang P, Zhang Z, et al: Inhibiting tumor necrosis
factor-alpha diminishes desmoplasia and inflammation to overcome
chemoresistance in pancreatic ductal adenocarcinoma. Oncotarget.
7:81110–81122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Piao MJ, Lee NH, Chae S and Hyun JW: Eckol
inhibits ultraviolet B-induced cell damage in human keratinocytes
via a decrease in oxidative stress. Biol Pharm Bull. 35:873–880.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang KA, Lee KH, Chae S, Zhang R, Jung MS,
Lee Y, Kim SY, Kim HS, Joo HG, Park JW, et al: Eckol isolated from
Ecklonia cava attenuates oxidative stress induced cell damage in
lung fibroblast cells. FEBS Lett. 579:6295–6304. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Harada D, Takigawa N and Kiura K: The Role
of STAT3 in non-small cell lung cancer. Cancers (Basel). 6:708–722.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grivennikov SI and Karin M: Dangerous
liaisons: STAT3 and NF-kappaB collaboration and crosstalk in
cancer. Cytokine Growth Factor Rev. 21:11–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ledoux AC and Perkins ND: NF-κB and the
cell cycle. Biochem Soc Trans. 42:76–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
